Scholarlink

Purpose of Review <p>To explore sex-specific dimensions of cardiovascular disease (CVD) by addressing key questions: (1) What is the true burden of CVD in women, and how does it compare with that in men across diverse populations? (2) Do risk factors for CVD differ between sexes in prevalence, biological impact, and prognostic significance? (3) Should we adopt sex-specific cardiovascular risk stratification tools to improve diagnostic precision in women? (4) Is there a need for earlier or more aggressive preventive strategies in women, particularly for those with sex-specific or predominant risk factors?</p> Recent Findings <p>CVD remains the leading cause of morbidity and mortality among women worldwide. Despite advances in care, significant sex-based disparities persist in awareness, diagnosis, risk stratification, and treatment. Women often present with distinct biological and psychosocial risk factors that are underrecognized in standard assessments. Emerging data support the development of sex-specific tools and earlier interventions tailored to these differences.</p> Summary <p>This review highlights the need for a more nuanced, sex-sensitive approach to CVD prevention and management. By reevaluating traditional risk frameworks and incorporating female-specific and underrecognized contributors, there is potential to improve outcomes and close the persistent care gap for women.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

How Can We Reduce Cardiovascular Risk in Women and Improve Risk Stratification?

  • 期刊论文

  • 发表日期：

    2025年8月19日

查看全文
  • Fabiana Hanna Rached,
  • Viviane Zorzanelli Rocha,
  • Thales Fraga Ferreira da Silva,
  • Francesca Maria DiMuro,
  • Roxana Mehran,
  • Lucas Lage Marinho

摘要

Purpose of Review

To explore sex-specific dimensions of cardiovascular disease (CVD) by addressing key questions: (1) What is the true burden of CVD in women, and how does it compare with that in men across diverse populations? (2) Do risk factors for CVD differ between sexes in prevalence, biological impact, and prognostic significance? (3) Should we adopt sex-specific cardiovascular risk stratification tools to improve diagnostic precision in women? (4) Is there a need for earlier or more aggressive preventive strategies in women, particularly for those with sex-specific or predominant risk factors?

Recent Findings

CVD remains the leading cause of morbidity and mortality among women worldwide. Despite advances in care, significant sex-based disparities persist in awareness, diagnosis, risk stratification, and treatment. Women often present with distinct biological and psychosocial risk factors that are underrecognized in standard assessments. Emerging data support the development of sex-specific tools and earlier interventions tailored to these differences.

Summary

This review highlights the need for a more nuanced, sex-sensitive approach to CVD prevention and management. By reevaluating traditional risk frameworks and incorporating female-specific and underrecognized contributors, there is potential to improve outcomes and close the persistent care gap for women.